News
SELLAS Life Sciences Gr Q4 EPS $(0.25) Misses $(0.21) Estimate
28 Mar 24
Earnings, Earnings Misses, News
SELLAS Announces Topline Data From Phase 2a Study of SLS009 In Relapsed/Refractory Acute Myeloid Leukemia And Provides Steering Committee Update on Phase 3 REGAL Study
26 Mar 24
Biotech, News, Health Care, General
Dow Falls Over 200 Points; Adobe Shares Plunge
15 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session
15 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
15 Mar 24
Movers
Crude Oil Edges Lower; US Consumer Sentiment Falls In March
15 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Nasdaq Down Over 100 Points; Hibbett Reports Downbeat Sales
15 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
12 Health Care Stocks Moving In Friday's Pre-Market Session
15 Mar 24
Movers
SELLAS Life Sciences Delivers Oral Presentation Of SLS009 Phase 1 Data For Acute Myeloid Leukemia Patients At 2024 European School of Haematology Conference
1 Mar 24
Biotech, News, Events, General
SELLAS Announces Publication Of Preclinical Data On Its Highly Selective CDK9 Inhibitor, SLS009, In Oncotarget
6 Feb 24
Biotech, News, General
Press releases
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma
28 Mar 24
Press Releases
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study
26 Mar 24
News, Press Releases
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
19 Mar 24
News, Press Releases
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
15 Mar 24
News, Financing, Press Releases
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
8 Mar 24
Press Releases
SELLAS Life Sciences Delivers Oral Presentation of SLS009 Phase 1 Data for Acute Myeloid Leukemia Patients at 2024 European School of Haematology (ESH) Conference
1 Mar 24
News, Health Care, Press Releases
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time
29 Feb 24
News, Health Care, Press Releases